Grow Therapy Expands Access to 180M Americans, Bolsters Privacy with Neosync Acquisition
Grow Therapy, a leading mental health care provider, has announced a significant expansion in accessibility and privacy measures. Over 180 million Americans can now access Grow Therapy through their health insurance plans, thanks to a strategic acquisition and technological advancement.
Grow Therapy has acquired Neosync, a pioneering Austrian company specializing in data privacy and security. This move aims to set a new standard in mental health privacy. Neosync's expertise will bolster Grow Therapy's anonymization technology, ensuring the protection of sensitive mental health data.
Founded in 2015, Grow Therapy has raised $178 million from prominent investors such as Sequoia Capital, Goldman Sachs Alternatives, and TCV. The platform empowers providers to deliver exceptional in-person and online therapy and psychiatric care, all covered by insurance. With this acquisition, Grow Therapy aims to innovate in areas of privacy and security, believing these aspects to be ripe for improvement in mental health care.
Aaltan Ahmad, Head of Security at Grow Therapy, underscores the importance of protecting personal stories behind mental health data. Grow Therapy's privacy principles include trustworthy innovation, strong data safeguards, and a consent-first approach. Evis Drenova, Neosync Co-Founder, joins Grow Therapy as Staff Product Manager, further strengthening the team's commitment to privacy and innovation.
With the acquisition of Neosync and the expansion of accessibility, Grow Therapy is poised to revolutionize mental health care. By prioritizing privacy and security, Grow Therapy ensures that over 180 million Americans can access mental health services with confidence and peace of mind.
